scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CELLSIG.2013.08.015 |
P8608 | Fatcat ID | release_zl3zcfhp7jdahkn2gcop5fqtxq |
P932 | PMC publication ID | 3865527 |
P698 | PubMed publication ID | 23993967 |
P5875 | ResearchGate publication ID | 256330557 |
P50 | author | Aleksander S. Popel | Q1642695 |
Feilim Mac Gabhann | Q87611742 | ||
P2093 | author name string | Wan Hua Tan | |
P2860 | cites work | Function, regulation and pathological roles of the Gab/DOS docking proteins | Q21245511 |
Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization | Q22009127 | ||
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments | Q24299236 | ||
Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF | Q24302435 | ||
Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis | Q24315718 | ||
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis | Q24318607 | ||
New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival | Q24336075 | ||
Ultrasensitivity in the mitogen-activated protein kinase cascade | Q24597665 | ||
VEGF signaling inside vascular endothelial cells and beyond | Q27687815 | ||
Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
VEGF receptor signalling - in control of vascular function | Q29617256 | ||
Systems biology of pro-angiogenic therapies targeting the VEGF system | Q30430112 | ||
The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling | Q30437567 | ||
Systems biology of vascular endothelial growth factors | Q30438979 | ||
Dimerization of VEGF receptors and implications for signal transduction: a computational study | Q30488864 | ||
Systematic quantification of negative feedback mechanisms in the extracellular signal-regulated kinase (ERK) signaling network. | Q30497351 | ||
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism | Q30504482 | ||
Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data | Q33401214 | ||
An inside view: VEGF receptor trafficking and signaling | Q33682832 | ||
Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells | Q33689582 | ||
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors | Q34121272 | ||
Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems | Q34292599 | ||
Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation. | Q34785695 | ||
The ubiquitin-proteasome system meets angiogenesis. | Q35815625 | ||
Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses | Q36254464 | ||
Role of lipids in the MAPK signaling pathway | Q36385228 | ||
Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops | Q36559220 | ||
VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF. | Q36752518 | ||
PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk | Q37133085 | ||
A methodology for performing global uncertainty and sensitivity analysis in systems biology. | Q37197756 | ||
Quantification of endothelial cell-targeted anti-Bcl-2 therapy and its suppression of tumor growth and vascularization | Q37419813 | ||
Four-dimensional dynamics of MAPK information processing systems. | Q37698293 | ||
In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis | Q37791747 | ||
Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer | Q37874750 | ||
Regulation of VEGF signaling by membrane traffic | Q38012210 | ||
Coordination of VEGF receptor trafficking and signaling by coreceptors. | Q38090234 | ||
Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival | Q39695672 | ||
Ligand-specific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics | Q39701404 | ||
Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. | Q39780346 | ||
Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells | Q39881261 | ||
The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. | Q40193180 | ||
Platelet-derived growth factor receptor-mediated signal transduction from endosomes | Q40609877 | ||
VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis | Q40713163 | ||
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity | Q40718829 | ||
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. | Q41791347 | ||
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2 | Q41900132 | ||
Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells | Q42199994 | ||
Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts | Q42799203 | ||
Quantitative model of Ras-phosphoinositide 3-kinase signalling cross-talk based on co-operative molecular assembly | Q42810205 | ||
VEGF receptor trafficking in angiogenesis | Q43243512 | ||
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. | Q51131994 | ||
Mathematical models of protein kinase signal transduction. | Q52039321 | ||
The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling. | Q52845770 | ||
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 | ||
Antiangiogenic therapy--evolving view based on clinical trial results. | Q53664329 | ||
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. | Q54735427 | ||
Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor | Q56689833 | ||
Giving Space to Cell Signaling | Q57711626 | ||
Raf Phosphorylation | Q58001193 | ||
VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment | Q58035861 | ||
Signal transduction by vascular endothelial growth factor receptors | Q84461284 | ||
P433 | issue | 12 | |
P921 | main subject | computational model | Q1122506 |
P1104 | number of pages | 15 | |
P304 | page(s) | 2496-2510 | |
P577 | publication date | 2013-08-29 | |
P1433 | published in | Cellular Signalling | Q1524097 |
P1476 | title | Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking | |
P478 | volume | 25 |
Q36273980 | Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells |
Q57467572 | Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides |
Q35108084 | Computational systems biology approaches to anti-angiogenic cancer therapeutics. |
Q55413755 | Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat. |
Q45051195 | Fibronectin fibrils regulate TGF-β1-induced Epithelial-Mesenchymal Transition. |
Q40463360 | Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling. |
Q60930788 | Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors |
Q47374262 | Netrin-1 Prevents Rat Primary Cortical Neurons from Apoptosis via the DCC/ERK Pathway |
Q58413005 | Quantifying the phosphorylation timescales of receptor-ligand complexes: a Markovian matrix-analytic approach |
Q28538791 | Quantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modeling |
Q42418396 | Quantitative insight in utilizing circulating angiogenic factors as biomarkers for antiangiogenic therapy: systems pharmacology approach |
Q39185970 | Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis. |
Q35661415 | Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model |
Q26850123 | Systems biology of the microvasculature |
Q35104052 | Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities |
Q52603017 | The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment. |
Q37545004 | VEGF regulates local inhibitory complement proteins in the eye and kidney. |
Q47100851 | VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways. |
Search more.